HTG Molecular Diagnostics, Inc. (HTGM)
(Delayed Data from NSDQ)
$2.59 USD
+0.10 (4.02%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.58 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
HTG Molecular Diagnostics, Inc. [HTGM]
Reports for Purchase
Showing records 1 - 20 ( 90 total )
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Three Milestones Achieved on the Drug Discovery Platform; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Full-Year 2022 Financial Results Reported; Reiterate Buy; Lowering PT to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Solid Progress in Drug Discovery Business; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Preliminary 2022 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
EdgeSeq RNA Profiling Highlighted; Reverse Stock Split Effected; Financing Completed; Reiterate Buy and Institute $15 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
2Q22 Financial Results Reported; Reiterate Buy; Modulating PT to $2
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
HTG Transcriptome Panel Highlighted in Customer Publication; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
1Q22 Financial Results Reported; Reiterate Buy; Modulating PT to $3
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Harmonization of miRNA and mRNA Profiling; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
2021 Financial Results Reported; Reiterate Buy; Reducing PT to $4
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Preliminary Full Year 2021 Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Transcriptome Panel Sample Types Expanded With Sequencer Flexibility; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Sales Milestone Achieved for Transcriptome Panel; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Modest Top-Line Miss, Bottom-Line Beat in 2Q21; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
New Drug Discovery Business Unit Established; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
First Commercial Orders Inked for Transcriptome Panel; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: HTG Molecular Diagnostics, Inc.
Industry: Medical - Instruments
Transcriptome Panel Design Lock; Three Collaborations Signed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y